market access

Views & Analysis

european countries 3d illustration - european continent marked with flags

Resourcing HTA across Europe

With the European Commission looking to formally strengthen health technology assessment (HTA) across Member States, Leela Barham attempts to assess and benchmark the resources currently d

News

Vertex and NHS close in on cystic fibrosis drug pricing deal

Vertex could be close to a price deal with the NHS over its portfolio of cystic fibrosis drugs, after health ministers wrote to the US firm asking for a conclusion to talks after almost two

News

GW prepares US for cannabis-based epilepsy drug

GW pushing for legal clearance in some states

News

Trump’s trade war with China could drive up US pharma costs

New tariffs on goods coming from China could hit the US pharmaceutical industry, according to a new analysis – and even undermine President Trump’s pledge to drive down the price of medicin

Views & Analysis

Close-up shot of an old rusty key inside a keyhole

Brexit makes UK pharma market less attractive – can a more c...

A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences through Brexit and beyond.

News